Research has demonstrated that the levels of SOX2 expression in prostate cancer tissues are markedly higher than those found in normal prostate tissues, and this elevated expression correlates with the prognosis of prostate cancer [31–33] (Table 2). The gene discussed is SOX2; the disease is prostate carcinoma.